Biomoda, Inc. (Public, OTC:BMOD)
With an unusual high volume of 930k so far, BMOD seems to be going higher on the anticipated news. Biomoda President, John Cousins believes BMOD may have Phase II results as early as the end of January 2010. Read here
BMOD on gekkowire
Biomoda at OneMedPlace (Link to presentation inside)
Wednesday, January 27, 2010
Subscribe to:
Post Comments (Atom)
If the Phase II trial results are good, this is going to sky-rocket out of this world. Too much upside to this company.
ReplyDelete